Reaction
Device Related Bacteraemia reporting signals
As of the last recalculation, Device Related Bacteraemia appears in 297 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 261.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Teduglutide | 43 | 261.3 | 262.2 |
| Thiotepa | 12 | 91.7 | 91.8 |
| Atovaquone | 10 | 90.0 | 90.2 |
| Daptomycin | 10 | 78.6 | 78.7 |
| Busulfan | 14 | 65.4 | 65.4 |
| Blinatumomab | 9 | 62.3 | 62.4 |
| Ursosiol | 15 | 56.9 | 56.9 |
| Ursodiol | 15 | 50.8 | 50.8 |
| Melphalan | 13 | 41.8 | 41.9 |
| Isotretinoin | 17 | 25.5 | 25.5 |
| Paricalcitol | 5 | 25.2 | 25.2 |
| Atezolizumab | 13 | 24.5 | 24.5 |